Display options
Share it on

Front Vet Sci. 2021 Jun 29;8:663656. doi: 10.3389/fvets.2021.663656. eCollection 2021.

Flow Cytometric Assessment of Ki-67 Expression in Lymphocytes From Physiologic Lymph Nodes, Lymphoma Cell Populations and Remnant Normal Cell Populations From Lymphomatous Lymph Nodes.

Frontiers in veterinary science

Barbara C Rütgen, Daniel Baumgartner, Andrea Fuchs-Baumgartinger, Antonella Rigillo, Ondřej Škor, Sabine E Hammer, Armin Saalmüller, Ilse Schwendenwein

Affiliations

  1. Clinical Pathology, Department of Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria.
  2. Institute of Pathology, Department of Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria.
  3. Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
  4. Clinic for Internal Medicine, Department for Small Animals and Horses, University of Veterinary Medicine Vienna, Vienna, Austria.
  5. Institute of Immunology, Department of Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria.

PMID: 34268346 PMCID: PMC8276100 DOI: 10.3389/fvets.2021.663656

Abstract

Recent literature suggests conventional flow cytometric (FCM) immunophenotyping complemented by Ki-67 FCM assessment as a reliable tool to classify canine lymphomas. Ki-67 expression assessed by FCM is rarely reported in canine lymphoma cases and reference data for normal canine lymph nodes are missing. Moreover, nothing is known about the Ki-67 expression within the occasionally observed remnant cell population within the gates of normal lymphocytes in lymphoma cases. Aim of this study was to compare flow cytometric Ki-67 expression of lymphocyte populations from normal canine lymph nodes, lymphoma cells from World-Health-Organisation (WHO) classified lymphoma patient samples and their neighboring normal remnant cell population. Cryopreserved lymphocyte cell suspensions from normal lymph nodes from eight dogs free of lymphoma served as reference material. Fourteen cases diagnosed by cytology, FCM, clonality testing, histopathology including immunohistochemistry consisting of 10 DLBCL, 1 MZL, 1 PTCL and 2 TZL showed a residual small lymphocyte population and were investigated. The Ki-67 expression in normal canine lymphoid tissue was 3.19 ± 2.17%. Mean Ki-67 expression in the malignant cell populations was 41 ± 24.36%. Ki-67 positivity was 12.34 ± 10.68% in the residual physiologic lymphocyte population, which otherwise exhibited a physiologic immunophenotype pattern. This ratio was equivalent (

Copyright © 2021 Rütgen, Baumgartner, Fuchs-Baumgartinger, Rigillo, Škor, Hammer, Saalmüller and Schwendenwein.

Keywords: Ki-67; canine lymphoma; flow cytometry; immunophenotyping; reference data

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Cell Prolif. 1992 Jan;25(1):31-40 - PubMed
  2. Vet Immunol Immunopathol. 2005 Jul 15;106(3-4):179-96 - PubMed
  3. Vet Immunol Immunopathol. 2005 Apr 8;104(3-4):239-47 - PubMed
  4. Leuk Res. 2010 Jul;34(7):932-8 - PubMed
  5. J Vet Intern Med. 2004 Sep-Oct;18(5):710-7 - PubMed
  6. Vet Pathol. 2016 Jul;53(4):711-25 - PubMed
  7. J Vet Intern Med. 2014 May-Jun;28(3):878-86 - PubMed
  8. Vet Clin North Am Small Anim Pract. 2013 Nov;43(6):1331-47, vii - PubMed
  9. Vet Pathol. 2020 Mar;57(2):214-226 - PubMed
  10. Pathologe. 2018 Dec;39(Suppl 2):272-277 - PubMed
  11. Vet Pathol. 1999 Jul;36(4):292-300 - PubMed
  12. Horm Mol Biol Clin Investig. 2017 Sep 22;32(2): - PubMed
  13. J Vet Intern Med. 2006 May-Jun;20(3):676-81 - PubMed
  14. Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):819-836 - PubMed
  15. J Small Anim Pract. 2001 Aug;42(8):377-84 - PubMed
  16. Vet Comp Oncol. 2017 Jun;15(2):431-440 - PubMed
  17. J Vet Intern Med. 2011 Sep-Oct;25(5):1097-105 - PubMed
  18. J Pathol. 1988 Mar;154(3):223-35 - PubMed
  19. Res Vet Sci. 2016 Jun;106:121-30 - PubMed
  20. J Comp Pathol. 2015 Feb-Apr;152(2-3):145-52 - PubMed
  21. Sci Rep. 2020 Oct 5;10(1):16447 - PubMed
  22. Vet Pathol. 2013 Sep;50(5):738-48 - PubMed
  23. Pathology. 2017 Feb;49(2):166-171 - PubMed
  24. Vet Pathol. 2018 Sep;55(5):645-653 - PubMed
  25. Vet Clin Pathol. 2015 Mar;44(1):58-69 - PubMed
  26. J Vet Diagn Invest. 2000 Mar;12(2):111-7 - PubMed
  27. Vet Pathol. 2011 Jan;48(1):198-211 - PubMed
  28. Pol J Vet Sci. 2012;15(4):727-34 - PubMed
  29. J Vet Diagn Invest. 2018 Mar;30(2):263-267 - PubMed
  30. J Comp Pathol. 2018 May;161:34-42 - PubMed
  31. Vet Pathol. 2006 May;43(3):241-56 - PubMed
  32. J Immunol. 1991 Dec 1;147(11):2474-82 - PubMed
  33. Vet Comp Oncol. 2015 Dec;13(4):475-80 - PubMed
  34. Vet Pathol. 2015 Jul;52(4):668-75 - PubMed
  35. Histopathology. 2006 Apr;48(5):505-15 - PubMed
  36. Vet Pathol. 2011 Jan;48(1):41-53 - PubMed
  37. Vet Pathol. 2016 Jan;53(1):37-43 - PubMed
  38. Front Vet Sci. 2021 Mar 19;8:600986 - PubMed
  39. Vet Comp Oncol. 2018 Jun;16(2):246-252 - PubMed
  40. J Vet Med Sci. 2016 Aug 1;78(7):1161-6 - PubMed
  41. Vet Clin North Am Small Anim Pract. 2017 Jan;47(1):53-70 - PubMed

Publication Types